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Abstract
Receptive ano-rectal intercourse is a major cause of HIV infection in men having sex with men and in heterosexuals. Current
knowledge of the mechanisms of entry and dissemination during HIV rectal transmission is scarce and does not allow the
development of preventive strategies. We investigated the early steps of rectal infection in rhesus macaques inoculated
with the pathogenic isolate SIVmac251 and necropsied four hours to nine days later. All macaques were positive for SIV.
Control macaques inoculated with heat-inactivated virus were consistently negative for SIV. SIV DNA was detected in the
rectum as early as four hours post infection by nested PCR for gag in many laser-microdissected samples of lymphoid
aggregates and lamina propria but never in follicle-associated epithelium. Scarce SIV antigen positive cells were observed
by immunohistofluorescence in the rectum, among intraepithelial and lamina propria cells as well as in clusters in lymphoid
aggregates, four hours post infection and onwards. These cells were T cells and non-T cells that were not epithelial cells,
CD68
+ macrophages, DC-SIGN
+ cells or fascin
+ dendritic cells. DC-SIGN
+ cells carried infectious virus. Detection of Env singly
spliced mRNA in the mucosa by nested RT-PCR indicated ongoing viral replication. Strikingly, four hours post infection colic
lymph nodes were also infected in all macaques as either SIV DNA or infectious virus was recovered. Rapid SIV entry and
dissemination is consistent with trans-epithelial transport. Virions appear to cross the follicle-associated epithelium, and also
the digestive epithelium. Viral replication could however be more efficient in lymphoid aggregates. The initial sequence of
events differs from both vaginal and oral infections, which implies that prevention strategies for rectal transmission will
have to be specific. Microbicides will need to protect both digestive and follicle-associated epithelia. Vaccines will need to
induce immunity in lymph nodes as well as in the rectum.
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Introduction
Receptive rectal intercourse with an HIV
+ individual carries a
per act risk of transmission of 0.5% to 1.7% [1–3]. This is three to
five-fold higher than receptive vaginal intercourse [3,4]. In 2009
Men having Sex with Men (MSM) represented 59.5% of all new
HIV infections in the USA [5], and 39.8% in Canada [6]. In
males, MSM represent 78.4% of newly acquired infections in the
USA [5], and 59.5% in Canada. MSM are the population group
with the highest risk of acquiring HIV worldwide, including
developing countries [7]. Rectal intercourse practiced in hetero-
sexual relationships [2,8–10] increases several fold the male to
female transmission risk [11–13].
Additionally, an increase in severity of disease for MSM with
respect to intravenous transmission has been noted in most but not
all cohorts [14–31]. This phenomenon could be due to the
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[31], such as HHV-8 [29,30]. Alternatively, entry by the rectal
route could modify the initial immune response and worsen the
clinical course of HIV infection [14].
HIV can cross the rectal epithelium by several mechanisms:
open lesion with direct access to blood leukocytes [32,33],
productive infection of epithelial cells [34–37], transcytosis by
epithelial cells [38,39] and/or M cells [40,41], opening of tight
junctions [42–44], and capture by intraepithelial dendritic cells
(DC) [45–48]. Transport of the virus out of the mucosa to lymph
nodes can be due to free virions in the lymph, infected cells or
virions bound to DCs [49], the C-type lectin DC-SIGN being then
a prime candidate for binding the virus [50–52].
For ethical reasons, in vivo data on viral entry and
dissemination can only be obtained in animal models. Experi-
mental infection of macaques with SIV currently represents the
best animal model for HIV infection [53,54]. Earlier work on
rectal infection in rhesus and pigtail macaques showed that viral
dissemination is rapid [55–59], proceeds in five stages with wide
animal to animal variation in terms of kinetics [55,56] and differs
from intravenous entry [55,56]. To our knowledge, no information
was gained on the pathway followed by the virus for rectal entry. A
good understanding of the mode of entry and of dissemination is
important for the development of preventive strategies, whether
chemical or vaccine based [44,60]. We decided to address this
question in the rhesus macaque (Macaca mulatta) following rectal
infection with the pathogenic isolate SIVmac251. We used free
virions as inoculum. Current data does suggest that during sexual
HIV transmission the source virus more likely originates from free
viral particles than from infected cells in seminal plasma [61,62].
We show here that SIV is present in lymphoid aggregates as
well as in the lamina propria of the rectum at least four hours post
infection (pi). Replication appears to be initiated mostly in
lymphoid aggregates. SIV disseminates away from the mucosa in
less than four hours after rectal infection. The first target cells of
SIV include T cells, but virus is also found associated with DC-
SIGN
+ cells. Presence at both sites (lymphoid aggregates and
lamina propria) suggests entry via digestive epithelium as well as
via follicle-associated epithelium. Prevention strategies will there-
fore have to cover these two sites.
Results
Experimental design
Rectal infections were performed with one hundred rectal
Animal Infectious Dose 50 (rAID50). This corresponds to 7.78 log
copies of viral RNA, for a final concentration of 7.31 log copies/ml
of viral RNA. This is commensurate with the highest viral loads
reported in human semen of 7 to 8.5 log copies/ml of viral RNA
[63–70]. Macaques were necropsied four hours (R-H4.1 and R-
H4.2), sixteen hours (R-H16.1, R-H16.2 and R-H16.3), twenty-
four hours (R-H24.1 and R-H24.2), two, three and four days (R-
D2.1, R-D2.2, R-D3.1, and R-D4.1) post infection and viral
distribution was analyzed by nested PCR, nested RT-PCR,
immunohistochemistry and co-culture with indicator cells. Plasma
viral load was below detection for R-H16.1, R-H24.1, R-H24.2,
R-D2.1, R-D2.2, R-D3.1 and R-D4.1. It was not measured for R-
H4.1, R-H4.2, R-H16.2 and R-H16.3 as it was assumed to be
below detection considering the early time point at which the
macaques were necropsied.
The macaque rectum is 7 cm long, 6 cm circumference [71].
Most often the entire rectum was prepared for morphology (with
alternate segments embedded in paraffin and frozen for cryosec-
tionning). For some macaques alternate segments (representing
one half of the rectum) were chemically and enzymatically
disrupted to obtain cell suspensions enriched for epithelial cells
(R-H4.1, R-H24.1, R-D2.2, R-D4.1) or for lamina propria cells
(R-H16.3).
Peripheral blood mononuclear cells (PBMC) were purified by
density centrifugation.
Individual colon-draining mesenteric lymph nodes were either
processed for morphology (some embedded in paraffin and others
frozen for cryosectionning) or were mechanically disrupted to
obtain a suspension of mononuclear cells. Axillary lymph nodes
were usually separated in two, which were processed for
morphology or mechanically disrupted to yield mononuclear cells.
Three macaques were sacrificed five (R-D5.1), seven (R-D7.1)
and nine (R-D9.1) days pi. This allowed us to determine that the
100 rAID50 dose leads to viral dissemination pattern similar to
those previously observed with ten rAID50 (Text S1, Figure S1).
Controls included macaques infected with heat-inactivated virus
and sacrificed four (M-H4.1), sixteen (M-H16.1) and twenty-four
(M-H24.1) hours post inoculation, as well as two healthy rhesus
macaques. Control rhesus macaques gave negative results in all
assays for SIV.
SIV enters intraepithelial cells but is not amplified in
rectal epithelia
Rare SIV antigen positive (SIV
+) intraepithelial cells were
observed by immunohistofluorescence (IHF) four, sixteen and
twenty-four hours pi (Figure 1, Text S1, Table S1 and Figure S2A).
Some of these cells were confirmed to be T cells (Figures 1A–D). In
contrast, IHF did not show SIV
+ epithelial cells at any time point.
The presence of SIV
+ intraepithelial cells indicates that the virus
could have crossed the digestive epithelium in less than four hours.
We never found SIV
+ cells by IHF in the follicle-associated
epithelium. We also never found viral DNA amplified by PCR in
laser microdissected follicle-associated epithelium (microdissection
described in Text S1 and Figures S3A and S3B).
The epithelial cell fraction contains cells from the digestive
epithelium, with less than 0.1% of cells coming from the follicle-
associated epithelium [72]. Very little, if any, cell-associated virus
was found in cells isolated from the rectal epithelium (Figure 2E),
indicating that there was no viral amplification in cells of the
epithelium. Cell-associated virus could correspond to infected
intraepithelial T cells.
SIV reaches mucosal lymphoid aggregates as early as
four hours post infection
Four hours pi and onwards, we detected viral DNA in
microdissected lymphoid aggregates in all macaques (Figure 2A,
example of microdissected area in Figures S3C and S3D). Over
60% of lymphoid aggregates were positive for SIV DNA at four
and sixteen hours pi (Figure 2A). Moreover, at least one third of
these positive aggregates contained more than one copy of SIV
DNA (with up to 20/20 PCR positive for SIV DNA, Table S2).
The number of copies of SIV DNA in microdissected samples was
below the detection limit of real-time PCR, preventing more
accurate quantification. The majority of lymphoid aggregates
remained positive for SIV at later time points (Figure 2A). In
addition, lymphoid aggregates could contain SIV DNA in several
serial sections suggesting local foci of infection (Table S2). The SIV
DNA load of lymphoid aggregates appeared stable from four to
forty-eight hours pi (Text S1, Figure S4A).
The presence of virus in lymphoid aggregates was confirmed by
IHF detection of capsid (p27) and envelope (gp130) proteins. Rare
clusters of adjoining cells showed labeling for SIV proteins in
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H, Table S1, Figure S2B), the latest time point examined. The
labeling was cytoplasmic, and appeared more punctate four hours
pi (Figure 2C, dashed circle) than at later time points (Figures 2E–
H). A control antibody of the same isotype as the antibodies to p27
and gp130 failed to bind on serial sections, demonstrating that
binding is specific (Figures 2I–L). The number of SIV
+ cell clusters
in the lymphoid aggregates appeared to increase slightly at days
one and two pi (Text S1, Table S1 and Figure S2B).
SIV
+ cells were phenotyped. Both CD3
+ and CD3
2 cells were
found positive for SIV antigens in the clusters (Figures 2B, 2D, 2F
and 2H). SIV
+ CD3
2 cells were negative for fascin, a marker for
mature DCs (Figure 2B) and for a macrophage-specific epitope of
CD68 (Figure 2D). Early targets of SIV include therefore T cells as
well as unidentified cells which do not appear to be mature DCs or
macrophages.
The presence in lymphoid aggregates of viral DNA and cells
positive for SIV antigens as early as four hours pi is a strong
indication that entry can occur through follicle-associated epithe-
lium. The slight increase over time suggests local viral replication.
SIV also reaches the lamina propria four hours post
infection
The lamina propria was infected as early as four hours pi as
shown by detection of viral DNA (Figures 3A and S4B) in laser-
microdissected samples (Figures S3E and S3F). Lamina propria
Figure 1. SIV is present in the rectal epithelium as early as four hours post infection. Serial paraffin sections of R-H4.1 (sacrificed four hours
pi; A and B) and R-H16.2 (sacrificed sixteen hours pi; C and D) were labeled by IHF for gp130 (Alexa-546, A and C), CD3 (TRITC, B and D) or fascin
(Alexa-488, B and D) and nuclei were stained with DAPI (A–D). CR, crypt; LP, lamina propria; RL, rectal lumen. Arrows on serial sections point to
intraepithelial T lymphocytes positive for SIV antigens. Cell-associated virus in the epithelial cell fraction was assayed by co-culture of cells isolated
from the rectum. Results are expressed as TCID50 per million cells. The viral load does not increase over the first four days of infection; + the TCID50
could not be calculated due to small number of wells positive for SIV antigen (E).
doi:10.1371/journal.pone.0019493.g001
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PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e19493Figure 2. SIV is present in lymphoid aggregates of the colo-rectal mucosa starting from four hours post infection. SIV DNA is amplified
by nested PCR for gag in most lymphoid aggregates microdissected from paraffin sections of macaques sacrificed four hours to two days pi (A); ratios
indicate the number of lymphoid aggregates positive for SIV DNA relative to the total number of lymphoid aggregates tested for each macaque.
Clusters of SIV-antigen positive cells are observed in paraffin embedded sections of the colo-rectal mucosa of R-H4.1 (sacrificed four hours pi; B, C and
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sample in the first day pi (Figure 3A). In contrast with lymphoid
aggregates, the ratio of positive PCRs never exceeded 3/10 in the
lamina propria (data not shown).
Infection of lamina propria was confirmed by IHF. Individual
SIV
+ cells were occasionally detected four hours to two days pi the
latest time point examined (Figures 3B and 3C). Of note, about
half of these cells were confirmed to be T cells (Figures 3B and
3C). The others were not T cells (CD3
2), DCs (fascin
2)o r
macrophages (negative for a macrophage-specific epitope of
CD68) (Figures 3B and 3C and data not shown). The number
of SIV antigen positive lamina propria cells appeared to decrease
over time (Figure S2C).
The presence of virus in the lamina propria could indicate that
the virus crossed the basement membrane in addition to the
digestive epithelium in less than four hours.
SIV mRNA production proceeds at a low level
We assayed for the presence of SIV Env singly spliced mRNA in
tissues of all macaques sacrificed between four hours and three
days pi (except R-H24.2). As RT-PCR could not be performed on
microdissected samples, the entire mucosa was used for detection
of spliced mRNA. It is therefore not possible in this assay to
discriminate between lymphoid aggregates and lamina propria.
Singly spliced mRNA was evidenced by nested RT-PCR in the
rectal mucosa of R-H4.1, R-H16.2 and R-D3.1 (Table 1). It was
never detected in control macaques. Detection of SIV Env singly
spliced mRNA in the tissues of infected macaques shows that
transcription and splicing proceed during the first days of rectal
SIV infection.
Heat-inactivated virus does not lead to detection of SIV
in the mucosa
Free viral DNA contained in viral stocks [73] could lead to false
positive PCR results at early time points. In order to ascertain that
the viral DNA detected in the mucosa of SIV inoculated macaques
was due to infection, we inoculated three macaques with a
quantity of heat-inactivated virus corresponding to 100 rAID50.
We necropsied them four, sixteen and twenty-four hours after
inoculation (macaques M-H4.1, M-H16.1 and M-H24.1 respec-
tively), and analyzed the rectal mucosa. No SIV DNA was ever
found in those samples despite performing over 220 individual
PCR for M-H4.1, 250 for M-H16.1 and 280 for M-H24.1 at
various dilutions to rule out PCR inhibition in the samples. This
indicates that free viral DNA cannot enter the rectal mucosa.
Therefore, the viral DNA observed four hours pi in the infected
macaques is indeed due to ongoing viral replication in the rectal
mucosa.
D, serial sections, dashed circle indicates the same area in the three micrographs), R-H16.1 (sacrificed sixteen hours pi; E, F enlargement of area boxed
in E), and R-H24.1 (sacrificed twenty-four hours pi; G, H enlargement of area boxed in G). These clusters of SIV
+ cells are not observed in serial sections
of R-H16.1 (I, J enlargement of area boxed in I) or R-H24.1 (K, L enlargement of area boxed in K) labeled with an irrelevant antibody of the same
isotype. These clusters contain T cells but not CD68
+ macrophages or fascin
+ DCs. Sections were labeled by IHF for gp130 (Alexa-546, C), p27 (Alexa-
488, E, F, G and H), CD3 (TRITC, B, D–H, K and L), fascin (Alexa-488, B), CD68 (Alexa-488, D), irrelevant antibody (Alexa-488 I–L) and nuclei were stained
with DAPI (B–L). CR, crypt; LP, lamina propria; TA, T cell area of mucosal lymphoid aggregate; BF, B cell follicle.
doi:10.1371/journal.pone.0019493.g002
Figure 3. SIV is present in the colo-rectal lamina propria as early as four hours post infection. SIV DNA is amplified by nested PCR for gag
in some lamina propria samples microdissected from paraffin sections four to twenty four hours pi (A); ratios indicate the number of lamina propria
sites positive for SIV DNA relative to the total number of lamina propria sites tested for each macaque. Serial paraffin sections of R-H16.3 (sacrificed
sixteen hours pi; B and C) were labeled for p27 (Alexa-488, B) and CD3 (TRITC, C) and nuclei were stained with DAPI (B and C). CR, crypt; LP, lamina
propria. Arrows on serial sections point to a lamina propria T lymphocyte positive for SIV antigen.
doi:10.1371/journal.pone.0019493.g003
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heat-inactivated virus did not show SIV
+ cells in the rectum of
these macaques (four to six different segments were extensively
sampled for each macaque). This indicates that the SIV
+ cells
observed in infected macaques correspond to live virions
internalized by cells or to infected cells.
We also did not find evidence for the presence of spliced mRNA
by nested RT-PCR in the macaques inoculated with heat-
inactivated virus, indicating that the detection of singly spliced
viral mRNA in infected macaques requires exposure to live virus.
Mucosal DC-SIGN
+ cells interact in vivo with SIV
As DC-SIGN can bind SIV, we localized and phenotyped DC-
SIGN-expressing cells by IHF early in infection. DC-SIGN
+ cells
were observed in lymphoid aggregates (Figure 4A) and in the
lamina propria (Figures 4B–D), but we never could detect
DC-SIGN
+ intraepithelial cells. Almost all DC-SIGN
+ cells co-
expressed a macrophage-specific epitope of CD68, indicating that
they are macrophages (Figure 4D). Most DC-SIGN
+ cells also
co-express PM-2K, marking them as mature macrophages
(Figure 4C). A few DC-SIGN
+ cells co-expressing MHC class II
could carry out antigen presentation (Figures 4A and 4B).
We tested interaction of SIV with DC-SIGN
+ cells on the rectal
collagenase fraction of macaque R-H16.3 (Figure 5). The enriched
DC-SIGN
+ cell fraction (Figure 5B) carried a 20-fold higher viral
load (Figure 5D) than the DC-SIGN
2 cells (Figures 5C and 5D)
from the same macaque. Nevertheless, we never observed by IHF
cells positive for both SIV and DC-SIGN.
SIV rapidly disseminates from the mucosa to the lymph
nodes
Viral DNA was detected as early as four hours pi in colic lymph
nodes but not prior to two days pi in axillary lymph nodes
(Table 2). Cell-associated virus was found in colic lymph nodes in
more than half of the macaques, and as early as four hours pi
(Table 3). In contrast it was only transiently detected twenty-four
hours pi in axillary lymph nodes (Table 3). Viral transcription was
below detection in colic and axillary lymph nodes (Table 1).
Viral DNA was however detected as early as twenty-four hours
pi in PBMC (Table 2). Cell-associated virus was also found in
peripheral blood as early as four hours pi, albeit at a lower level
(Table 3).
These data suggest that SIV disseminates in draining lymph
nodes at four hours pi and to axillary lymph nodes at later time
points.
Discussion
Despite the importance of rectal infection in the AIDS
epidemic, current knowledge regarding HIV rectal entry is limited
to in vitro work, which does not reproduce fully the complexity
and specificity of the rectal milieu. An understanding of HIV
mucosal entry would be of considerable help in the design of
microbicides and vaccines. We addressed the question of rectal
entry in the rhesus macaque infected by SIVmac251, the animal
model closest to the human infection by HIV [53,54]. In order to
increase our chances to detect virus during early acute infection,
we chose a viral dose ten times higher than in our previous work
[55,56]. This dose is in the low range of the doses used for studies
of vaginal transmission [74–78]. It is commensurate with the
highest viral loads reported in the semen of HIV
+ men [63–70].
This one hundred rAID50 dose does not affect the dissemination
profile.
SIV entry is massive. If we consider our sampling to be
representative of the entire rectum, one can estimate the viral
DNA in the rectum of each macaque four hours pi to be on the
order of 55,000 copies in lymphoid aggregates and on the order of
290,000 in the lamina propria (see Text S1 for details). As we
could not find SIV DNA in mock-infected macaques, this suggests
that approximately 3610
5 viral particles were able to cross the
rectal epithelia and undergo reverse transcription, representing
close to 1% of input viral particles. Some of these copies must be
integrated as spliced mRNA could be found in the rectum as early
as four hours pi. The much lower number of cells positive for SIV
antigens (on the order of 10
3–10
4 per macaque, Figure S2) suggests
that most copies of SIV DNA correspond to defective particles
undergoing abortive infection. Cells positive for SIV antigens can
be productively infected or have merely internalized viral antigens.
As, in vivo, the average life cycle of SIV is under 10 hours [79], it
is likely that the cells positive for SIV antigens observed sixteen
hours pi and onwards are infected cells in which translation
proceeds. The fraction of these cells which will go on to produce
virus is currently not possible to estimate.
SIV entry is a very rapid process, as infection is established in
the lamina propria, in lymphoid aggregates and in more distal sites
at least at four hours pi, the earliest time point assessed. Viral entry
after vaginal inoculation was shown, by in situ acidic inactivation,
to be complete in less than 30 minutes [77], with reverse
transcription completed as early as two hours pi [78]. The reverse
transcriptase inhibitor tenofovir applied rectally two hours after
rectal infection protected only one third of inoculated macaques
[80], indicating that reverse transcription can be completed in less
than two hours. This is faster than expected from in vitro work.
However, one should note that gut lymphocytes are inflammatory
but hyporesponsive [81], and that this may accelerate the viral
cycle. It was not possible to narrow down further the time
necessary for virus to be imported from the inoculum as, in our
hands, acidic inactivation was toxic by the rectal route.
SIV entry could involve trans-epithelial transport of SIV. Early
reports of HIV in rectal epithelial cells of HIV
+ patients [82–84]
have not been confirmed. Many now accept that infected
epithelial cells are not found in vivo [44,85]. In our previous
work we had not observed infected rectocytes [56]. In the present
work we could never observe infected epithelial cells either by IHF
or by ISH. We did find virus at distal sites as early as four hours pi.
Trans-epithelial transport is a likely explanation for this rapid
Table 1. Env singly spliced mRNA is detected earlier in the
colo-rectal mucosa than in lymph nodes.
Macaque
Colorectal
mucosa
Colic lymph
nodes
Axillary lymph
nodes
R-H4.1 + 22
R-H4.2 222
R-H16.1 222
R-H16.2 + 22
R-H16.3 222
R-H24.1 222
R-D2.1 222
R-D2.2 222
R-D3.1 + 22
The singly spliced mRNA for the Env gene was detected by nested RT-PCR in the
indicated tissues.
doi:10.1371/journal.pone.0019493.t001
Rectal SIV: Fast and Furious
PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e19493dissemination, as viral production in situ is unlikely over such a
short period of time. Indeed, the estimated mean intracellular
phase of the life cycle for HIV in vivo is 14.4 to 21.6 hours [86]. It
is shorter for SIV, with a mean life cycle of 9.4 hours [79]. The
trans-epithelial transport of SIV does not appear to involve
capture by DC processes extending into the rectal lumen through
tight junctions. Indeed, we never observed intraepithelial DCs at
early time points of infection using classical DC markers (DC-
SIGN, fascin). The presence of SIV in both lymphoid aggregates
and digestive mucosa four hours pi argues in favor of transcytosis
of virions by both the digestive epithelium and the follicle-
associated epithelium. One should note that entry appears more
efficient across the follicle-associated epithelium. However the
surface of the digestive epithelium is much larger than that of the
follicle-associated epithelium, and the amount of virus entering
through this route could be greater.
SIV structural proteins are found intracellularly by IHF in
intraepithelial cells (including T cells), in lamina propria cells
(T cells and non-T cells), and in T cell-containing clusters in
lymphoid aggregates. The non-T cells are neither macrophages
nor mature DCs as they do not express CD68, DC-SIGN or
fascin. The SIV antigen positive clusters probably correspond to
the infection of a single cell by virus from the inoculum. Secondary
diffusion of SIV antigen to neighboring cells could occur by
infection (a possibility for macaques infected sixteen hours and
onwards) or by cell-cell fusion. In favor of the former is the fact
that lymphoid aggregates often contain several copies of SIV DNA
(Table S2). SIV
+ cells are scarce and the detection of Env singly
Figure 4. DC-SIGN
+ cells are macrophages in the colo-rectal mucosa during the first sixteen hours of infection. DC-SIGN
+ cells are
observed in lymphoid aggregates of R-H4.2 (sacrificed four hours pi; A) and lamina propria of R-H4.1 (sacrificed four hours pi; C) and R-H16.3
(sacrificed sixteen hours pi; B and D). DC-SIGN
+ cells express only occasionally MHC-II molecules (A and B, arrows), but co-express PM-2K (C) and CD68
(D) marking them as macrophages. Frozen sections of colo-rectal mucosa were labeled for DC-SIGN (Alexa-488), CD3 (Alexa-350, A, B and D), MHC-II
Mamula-DR (Alexa-546, A, B and C) or PM-2K (Alexa-350, C), CD68 (Alexa-546, D) and nuclei were stained with TO-PROH-3 (A–D). The computer-
generated merged images are shown. CR, crypt; LP, lamina propria; S, submucosal connective tissue; TA, T cell area of mucosal lymphoid aggregate;
HEV, high endothelial venule.
doi:10.1371/journal.pone.0019493.g004
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replication is initiated in very few cells of the rectal mucosa at early
stages of infection. We have no evidence for viral production in the
digestive part of the mucosa. In contrast, the presence of SIV
+ cell
clusters suggests that viral production occurs in lymphoid
aggregates.
During the first day of infection at least, rectal DC-SIGN
+ cells
have an overall distribution pattern similar to healthy human and
macaque rectum [52,87]. They appear less abundant in the
lamina propria, but more abundant in lymphoid aggregates than
Jameson et al. observed in healthy rhesus macaque mucosa [87].
They all express macrophage markers, as was described in healthy
human rectum [52]. In contrast to healthy mucosa [52,87], in
early SIV infection rectal DC-SIGN
+ cells do not all express MHC
class II. DC-SIGN
+ cells bind infectious virions, as infectious virus
is enriched in the DC-SIGN
+ cell fraction. The number of virions
bound by each cell is presumably small as these cells are not
positive by IHF.
SIV dissemination is rapid as cell-associated virus could be
recovered from draining lymph nodes and from the peripheral
blood as early as four hours pi. This indicates that virus-carrying
cells have left the mucosa to percolate through the colic lymph
node chain and reach the circulation in less than four hours. The
very early presence of viral DNA in draining lymph nodes strongly
suggests that infected cells are one means of viral dissemination
from the mucosa. Virus could also travel as cell-bound virions.
This is one explanation of the discrepancy observed between co-
culture results and nested PCR results, the other one being a
Figure 5. Rectal DC-SIGN
+ cells can bind SIV sixteen hours post
infection. Flow cytometry analysis of cells from the rectal collagenase
fraction of R-H16.3 (sacrificed sixteen hours pi) shows enrichment of
DC-SIGN
+ cells from total cells (A) in the DC-SIGN
+ fraction (B) and
depletion in the DC-SIGN
2 fraction (C); left dot plots show side scatter
(SSC) versus forward scatter (FSC) and gate in which expression of DC-
SIGN is analyzed; right histograms show expression of DC-SIGN and
percentage of DC-SIGN
+ cells (bar on histogram); gray filled histogram
in A corresponds to isotype control. Cell-associated viral load (expressed
as TCID50 per million cells; D) shows that over twenty-fold more cell-
associated virus is found in the DC-SIGN enriched cell fraction than in
the DC-SIGN depleted cell fraction (D).
doi:10.1371/journal.pone.0019493.g005
Table 2. Viral DNA is detected in colic lymph nodes prior to
peripheral blood and axillary lymph nodes.
Macaque Colic lymph nodes Axillary lymph nodes PBMC
R-H4.1 22 2
R-H4.2 + 22
R-H16.1 22 2
R-H16.2 + 22
R-H16.3 + 22
R-H24.1 + 2 +
R-H24.2 22 +
R-D2.1 +* +* +
R-D2.2 + 2 +
R-D3.1 ++ * 2
R-D4.1 ++
1 +
The presence of viral DNA was assayed on cell suspensions, on OCT-frozen
samples (*) or on paraffin sections (
1). +: viral DNA detected; 2: no viral DNA
detected. PBMC: peripheral blood mononuclear cells.
doi:10.1371/journal.pone.0019493.t002
Table 3. Cell-associated virus is detected rapidly in lymph
nodes and peripheral blood.
Macaque Colic lymph nodes Axillary lymph nodes PBMC
R-H4.1 2 22
R-H4.2 1 2 1
R-H16.1 4 2 2
R-H16.2 * 22
R-H16.3 22 *
R-H24.1 2 * 2
R-H24.2 13 * 2
R-D2.1 22 2
R-D2.2 9 2 *
R-D3.1 22 1
R-D4.1 22 2
Results are expressed as TCID50 per million cells.
*at least one well was positive for SIV antigen, but the TCID50 could not be
calculated due to small number of SIV antigen positive wells. 2 no SIV antigen
positive well in the experiment. PBMC: peripheral blood mononuclear cells.
doi:10.1371/journal.pone.0019493.t003
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transport as free virions in the lymph draining the rectum. To
determine whether this occurs, one would have to cannulate
lymph from the colon under prolonged anesthesia. This not only
raises technical and ethical concerns, but could also modify
exchanges between lymphoid tissues.
Rectal infection appears to involve rapid entry and reverse
transcription, as has been noted for the vaginal [77,78] and oral
routes[88] buttherearecleardifferenceswith theseentry pathways.
Dissemination after rectal entry is possibly more rapid than after
oral entry, where SIV DNA is found in many lymphoid tissues
twenty-four hours pi [88]. It is also more rapid than following
vaginal entry, where SIV DNA could be found at very low-levels in
draining lymph nodes eighteen hours pi and in some lymphoid
tissues twenty-four hours pi [77]. We found that a high proportion
of virus crosses the epithelium upon rectal inoculation. This is
similar to oral infection [88], but contrasts with vaginal entry where
only a very small proportion of the total inoculum enters the vaginal
mucosa [78]. We show that T cells, but not fascin positive DCs or
macrophages, are among the first targets of SIV during rectal
transmission. This is not the case during vaginal transmission where
fascin positive DCs are the first cells associated with SIV [77] or
during oral infection where macrophages are infected [88].
The rapid kinetics of rectal entry and dissemination has
important consequences for the development of preventive
strategies. Rhesus macaques can be protected from rectal infection
by tenofovir applied locally prior to inoculation [80]. Protection is
not observed if the plasma concentration of tenofovir is below
75 ng/ml. This is in contrast with what is observed for vaginal
infection, where protection is observed with plasma concentrations
of tenofovir as low as 11 ng/ml [89]. This suggests that protection
from rectal infection (and possibly not from vaginal infection)
requires inhibition of reverse transcription in distal sites such as
lymph nodes and not exclusively in the rectum. One cannot exclude
that routine use of reverse transcriptase inhibitors with such plasma
concentrations will lead to side effects and present risks of selection
for resistant reverse transcriptase mutants. Therefore, there is a use
for microbicide preparations for rectal use aiming to prevent virion
interaction with the epithelium (digestive as well as follicle-
associated) and entry into cells. This would complement (or replace)
preparations aiming to block reverse transcription.
In conclusion, we show that SIV crosses in less than four hours
both the digestive epithelium and the follicle-associated epithelium.
We propose that entry occurs by transcytosis at both sites, with
rectocytes and M cells being the most likely candidates to carry out
transcytosis of virions. Following entry, SIV infects T cells as well as
non-T cells in the mucosa. SIV initiates replication locally in the
rectal lymphoid aggregates, and to a lower extent in the lamina
propria. Virus is rapidly transported to distal sites as infected cells, as
virions associated with cells possibly expressing DC-SIGN or as free
virions present in the lymph. Reverse transcription occurs in the
rectalmucosaduringthefirsthoursofinfection.Reversetranscription
may alsooccur in draining lymph nodes. To be effective against rectal
transmission of HIV, a vaccine will have to induce immunity at the
rectal surface, but also in distal lymphoid sites.
Methods
Macaques and tissue collection
Macaques were housed at the L3 animal facility of the Pasteur
institute (France) in accordance with the European Community
guidelines (Journal Officiel des Communaute ´s Europe ´ennes,
L358, December 18, 1986). C. Butor was granted for this
protocol the authorization to experiment on live non-human
primates number 006322 by the Ministe ` r ed el ’ A g r i c u l t u r ee td e
la Pe ˆche in 1994, then the authorization to experiment on live
non-human primates number 78-76 by the Pre ´fecture des
Yvelines in 2005. A. Coue ¨del-Courteille was granted the
authorization to experiment on live non-human primates
number 007304 by the Ministe ` r ed el ’ A g r i c u l t u r ee td el a
Pe ˆche in 1997, then the authorization to experiment on live
non-human primates number 75-1068 in 2005. Several steps
were taken to improve animal welfare according to the
recommendations of the Weatherall report. Animals were
housed in individual cages to prevent viral transmission, but
up to twenty animals were housed in a single room allowing
sight and sound contact with each other. Diet was supplemented
with a variety of fresh fruit. All manipulations of animals were
performed under ketamine anesthesia, according to regulations
in France. Macaques were sacrificed by a lethal dose of
pentothal under ketamine anesthesia. In addition, the tissues
obtained after necropsies are currently used for another study in
order to reduce the total number of animals used. Nineteen
adult male rhesus macaques (Macaca mulatta)w e r eu s e di nt h i s
study. Fourteen macaques were inoculated atraumatically by the
rectal route with 100 rAID50 [90] and otherwise as previously
described [55,56]. This corresponds to 18,000 TCID50 and 7.78
log copies of viral RNA [91] for a final concentration of 7.31 log
copies/ml of viral RNA. The SIVmac251 viral stock originally
obtained from R Desrosiers was a kind gift of A-M Aubertin.
Macaques were sacrificed four hours (animals R-H4.1 and R-
H4.2), sixteen hours (R-H16.1, R-H16.2 and R-H16.3), twenty-
four hours (R-H24.1, R-H24.2), two days (R-D2.1, R-D2.2) and
three, four, five, seven and nine days (R-D3.1, R-D4.1, R-D5.1,
R-D7.1 and R-D9.1) pi. Three animals were inoculated with an
identical volume of the viral stock after heat inactivation (56uC
for 30 min) and euthanized four, sixteen or twenty-four hours
post inoculation (M-H4.1, M-H16.1 and M-H24.1 respectively).
Two healthy rhesus macaques were used as controls. Peripheral
blood was collected on heparin or EDTA prior to euthanasia.
Lymph nodes, colon and rectum were collected separately under
sterile conditions and processed as previously described [56],
omitting the Percoll gradient on the epithelial and collagenase
fractions.
Titration of cell-associated virus
Titrations were performed as previously described [55,56]. For
macaques R-H4.1 R-H4.2, R-H16.2 and R-H16.3 we used the
commercial kit ÆÆInnotestH HIV Antigen P24ææ (Innogenetics,
Gent, Belgium) which cross-reacts with the SIV p27 capsid protein
instead of our homemade ELISA. The TCID50 was calculated
according to Reed and Muench [92].
In situ hybridization
ISH was performed as previously described [56] using either
INT-BCIP or NBT-BCIP as substrate for alkaline phosphatase.
Immunohistofluorescence
Five mm-thick formaldehyde-fixed paraffin-embedded sections
collected on glass slides were deparaffinized and rehydrated.
Antigen retrieval was performed by pressure cooking the sections
for 10 min in 0.01 M buffered sodium citrate solution (pH 6).
Sections were then rinsed with calcium free Dulbecco’s phosphate
buffered saline (PBS). Seven mm-thick cryosections were fixed for
10 min in cold acetone and rinsed in PBS.
Both types of sections were incubated for 30 min with blocking
buffer (2% normal goat serum and 5% bovine serum albumin in
PBS), incubated for 60 min with primary antibodies, washed in
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secondary antibodies for 30 min, washed, counterstained with 4,6-
diamidino-2-phenylindol (DAPI) (Molecular Probes, Cergy Pon-
toise, France, paraffin sections) or TO-PROH-3 iodide (Invitrogen,
Cergy Pontoise, France, cryosections) and mounted in Fluoro-
mount-G (Southern Biotechnology, Birmingham, AL).
Primary antibodies were polyclonal rabbit anti-CD3 (DAKO,
Trappes, France) mouse monoclonal antibodies to fascin (clone
55K-2, IgG1, DAKO), SIV gp130 envelope protein (clone
KK46, IgG1, obtained from the NIH), SIV p27 capsid protein
(IgG1, Advanced Biotechnologies Inc Columbia, MD), Aspergil-
lus niger glucose oxidase (isotype control, IgG1, clone DAK-
GO1, DAKO), HLA-DR (clone TU ¨36, IgG2b, BD Biosciences),
DC-SIGN (clone 120612, IgG2a, R&D Systems, Lille, France),
DC-SIGN (clone 120507, IgG2b, R&D Systems), CD68 (clone
KP1, IgG1, DAKO, Trappes, France), and tissue macrophage
(clone PM-2K, IgG1, AbD Serotec, Du ¨sseldorf, Germany).
Secondary antibodies were TRITC-conjugated goat anti-rabbit
antibody (Southern Biotechnology) and isotype-specific (IgG1,
IgG2a and IgG2b) goat anti-mouse secondary antibodies
(Molecular Probes) conjugated to Alexa 350, Alexa 488 or
Alexa 546.
Image capture and analysis
IHF sections were examined under an inverted epifluorescence
microscope Axiovert 200 M (Zeiss), equipped with a HBO flexible
fluorescence lamp, a black and white CCD camera (Roper
Scientific Coolsnap HQ) and coupled to video imaging using the
Axiovision 4.4 software (Zeiss). ISH sections were examined under
a DMRB (Leica) with a DC300F camera (digital module R, Leica)
and the IM1000 software (Leica). Images were digitally acquired
with a 206or a 406objective, then we used both the Axiovision
software and the Photoshop software (Adobe Systems Incorporat-
ed) to analyze the different stainings.
Laser capture microdissection of rectal mucosa
Microdissection was performed on an automated system for
diode ultraviolet laser cutting and infrared laser capture of tissue
samples, mounted on a Nikon Eclipse TE2000 inverted
microscope equipped with a color CCD camera and coupled to
video imaging. Formaldehyde-fixed paraffin-embedded 5-mm-
thick sections were mounted on a polyethylene foil slide (SL
Microtest GmbH, Jena, Germany) and counterstained with
hematoxyline. Sections were observed on a screen using a 106
or a 206objective. An incision path was drawn on the screen and
multiple overlapping laser pulses dissected the selected tissue
area. The target tissue was removed from the slide with isolation
caps. The efficiency of the laser capture microdissection was
assessed by examining the tissue harvested under the microscope.
DNA was extracted by adapting the DNeasy blood and tissue kit
protocol from QIAGEN (Courtaboeuf, France) for small DNA
amounts.
Detection of SIV viral DNA
DNA was extracted from 5610
6 cells in suspension using the
DNeasy blood and tissue kit (QIAGEN) and from paraffin
sections using the DNeasy tissue kit (QIAGEN) according to the
manufacturer’s instructions. To assess the quality of the extracted
DNA (presence of cellular DNA, lack of PCR inhibitor), we
performed a PCR for actin using sense (59 GGG TCA GAA
GGA TTC CTA TG 39) and antisense (59 GGT CTC AAA CAT
GAT CTG GG 39) actin primers (Genset, Paris, France). To
assess the presence of viral DNA, we used either a semi-nested
PCR protocol as previously described [55,93] or a single PCR
protocol with primers F-GAG-Ni-59-CCG TCA GGA TCA
GAT ATT GCA and R-GAG-Ci-59-TTC GTA CCC AGC
CCC TTC AGC in 2.5 mM MgCl2. Ten to twenty individual
PCRs were performed on mucosa samples. Negative PBMC and
lymph node samples were tested at varying dilutions to rule out
potential inhibition of the PCR due to suboptimal ratios between
the DNA and the primers in the sample. The detection threshold
was one to two copies as assessed with serial dilution of gag
containing plasmids in different volumes of DNA extracts
obtained from PBMC or from microdissected tissues of
uninfected macaques.
Purification of DC-SIGN-expressing cells from the rectum
DC-SIGN-expressing cells were enriched using anti-phycoery-
thrin (PE) magnetic beads (Miltenyi Biotec) according to
manufacturer’s recommendations. Briefly lamina propria rectal
cells were stained with an anti-DC-SIGN-PE antibody (clone
120507, R&D Systems), washed in MACS buffer (Miltenyi Biotec),
incubated with anti-PE beads, then separated in a LS column
(Miltenyi Biotec). The column was washed with MACS buffer and
DC-SIGN-expressing cells were eluted. Both positive and negative
fractions were washed, analyzed by flow cytometry and used to
quantify cell-associated virus. Flow cytometry was performed on a
FACSCalibur or a FACSCanto (BD Biosciences) and analyzed
with FlowJo 8.8.6 software (TreeStar).
Detection of Env singly spliced mRNA
Messenger RNA was extracted with the MicroPoly(A) Purist
kit (AMBION, Courtaboeuf, France) according to manufactur-
er’s instructions from samples of colorectal mucosa, colic and
axillary lymph nodes (1 mm
3)f r o z e ni nO C T .T oa s s e s st h e
presence of Env singly spliced mRNA, we used a nested RT-
PCR protocol. After a reverse transcription step, cDNAs were
first PCR amplified with primers LTR-SIV-SD-59-CGA CGG
AGT GCT CCT ATA AA (located before the splice donor in
the long terminal repeat region in 59) and V1V2-Out3-59-GAA
GAG ACC ACC ACC TTA GAA (located before the Rev
response element). A second PCR was performed on the initial
PCR products with primers V1V2-In5-59-AGG ATG TAT
GGC AAC TCT TTG A and V1V2-In3-59-CAC AAG ACT
CTT GGA TAA CAG AA. All PCRs were performed in
3.5 mM MgCl2 with 10 minutes initial denaturation at 95uC,
then 35 cycles of 30 seconds at 94uC, 30 seconds at 60uC, and
5m i n u t e sa t7 2 uC.
Supporting Information
Figure S1 SIV dissemination after high dose rectal
infection reaches colon draining lymph nodes prior to
axillary lymph nodes. Cell-associated virus in tissues expressed
as TCID50 per million cells shows more than one log difference
between draining lymph nodes and other lymphoid tissues; + the
TCID50 could not be calculated due to small number of wells
positive for SIV antigen (A). SIV DNA amplified by nested PCR
for gag is always found in draining lymph nodes, but not in other
lymphoid tissues of R-D9.1: + viral DNA amplified, 2 no viral
DNA amplified (B). Infected cells are detected by in situ
hybridization for SIV in colic lymph node of R-D5.1 (C), rectal
mucosa of R-D7.1 (D) and central mesenteric lymph node of R-
D9.1 (E). C, INT-BCIP substrate, no counterstain; D and E NBT-
BCIP substrate, eosin counterstain. Arrows point to infected cells
in lymph nodes (C and E) and in the T cell area of mucosal
lymphoid aggregates (D) and arrowheads to infected cells in the
lamina propria (D). CR, crypt; LP, lamina propria; S, submucosal
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GC, germinal center; FM, follicular mantle; BF, B cell follicle; PC,
parafollicular cortex.
(TIF)
Figure S2 SIV-antigen positive elements during the first
two days of infection. SIV-antigen positive intraepithelial cells
(A), clusters in lymphoid aggregates (B) or lamina propria cells (C)
were counted on sections labeled by IHF. Total values were
computed per macaque.
(TIF)
FigureS3 Lasercapturemicrodissectionallowsseparate
sampling of follicle-associated epithelium, lymphoid
aggregates and laminapropria. Figure shows paraffin sections
counterstained with hematoxylin and micrographed with an Eclipse
TE2000 inverted microscope before (A, C, E) and after (B, D, F)
laser capture microdissection. The red dashed line corresponds to
the laser pattern. The area microdissected in A and B was follicle
associated epithelium (FAE), in C and D lymphoid aggregate (LA)
and in E and F lamina propria (LP).
(TIF)
Figure S4 Number of copies of SIV DNA during the first
two days of infection. The presence of SIV DNA was measured
by semi-quantitative PCR on microdissected lymphoid aggregates
(A) and lamina propria (B). See text for details of calculations.
(TIF)
Table S1 Number of SIV antigen positive cells or cell
clusters in colo-rectal segments during the first two days
post infection.
(DOC)
Table S2 PCR analysis of SIV DNA on serial sections of
colo-rectal lymphoid aggregates.
(DOC)
Text S1
(DOC)
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